BackPoseida Therapeutics Overview

Poseida Therapeutics Total Revenue

Revenue analysis for PSTX.

Quarterly Revenue

$71.75M
↑ 667.19% YoY

As of Sep 2024

Annual Revenue (TTM)

$150.86M
↑ 203.18% YoY

Trailing 12 months ending Sep 2024

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin